Header cover image

Global Pharmaceuticals & Biotech Established, Profitable and Undervalued

UPDATED Jul 03, 2022

Over $1bn in market cap, profitable and undervalued based on cash flows.

63 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
JNJJohnson & JohnsonUS$179.52-1.5%6.2%US$472.4bUS$187.28PE23.8xE4.4%2.5%
PFEPfizerUS$52.311.4%31.7%US$293.5bUS$57.00PE11.6xE-18.0%3.1%
LLYEli LillyUS$324.71-0.3%38.8%US$292.3bUS$316.41PE47.7xE20.1%1.2%
ROGRoche HoldingCHF320.400.5%-8.3%CHF262.0bCHF386.26PE18.4xE7.4%2.9%
ABBVAbbVieUS$153.801.0%33.5%US$271.8bUS$162.17PE21.9xE-0.6%3.7%
NOVO BNovo Nordiskkr.784.60-0.2%47.9%kr.1.8tkr.813.00PE36.1xE13.8%1.3%
MRKMerckUS$92.42-0.8%17.6%US$233.7bUS$96.59PE16.8xE11.8%3.0%
TMOThermo Fisher ScientificUS$548.270.6%6.8%US$214.6bUS$661.95PE28.2xE9.1%0.2%
NOVNNovartisCHF80.33-0.3%-5.0%CHF174.5bCHF91.19PE7.5xE2.8%3.7%
BMYBristol-Myers SquibbUS$76.84-2.7%14.8%US$163.6bUS$79.05PE26.2xE14.0%2.8%
AMGNAmgenUS$245.550.3%-1.3%US$131.2bUS$246.51PE22.9xE9.7%3.2%
SANSanofi€97.52-3.0%10.9%€121.9b€114.78PE18.3xE8.0%3.4%
GSKGSKUK£17.861.7%24.2%UK£90.4bUK£18.69PE17.7xE10.4%4.5%
CSLCSLAU$274.800.7%-2.6%AU$129.7bAU$319.21PE38.6xE14.8%1.2%
ZTSZoetisUS$174.21-0.2%-9.6%US$82.0bUS$233.50PE39.6xE11.4%0.7%
GILDGilead SciencesUS$62.36-0.7%-10.0%US$78.2bUS$69.65PE17.3xE8.3%4.7%
MRKMERCK Kommanditgesellschaft auf Aktien€165.700.5%1.8%€72.0b€210.34PE22.6xE6.3%1.1%
VRTXVertex PharmaceuticalsUS$287.320%43.3%US$73.5bUS$294.22PE30xE10.3%n/a
REGNRegeneron PharmaceuticalsUS$595.40-1.2%2.0%US$64.2bUS$679.24PE8.1xE-3.2%n/a
BAYNBayer€57.35-0.8%11.4%€56.3b€79.37PE25.6xE8.7%3.5%
4568Daiichi Sankyo CompanyJP¥3,411.002.6%45.4%JP¥6.5tJP¥4,135.71PE97.6xE28.8%0.8%
603259WuXi AppTecCN¥109.115.5%-29.1%CN¥298.6bCN¥156.29PE61.6xE22.7%0.5%
4502Takeda PharmaceuticalJP¥3,812.001.0%2.7%JP¥5.8tJP¥4,468.13PE25.6xE8.7%4.7%
4519Chugai PharmaceuticalJP¥3,529.00-1.3%-18.5%JP¥5.7tJP¥4,577.69PE15xE0.8%2.2%
Page 1 of 3